These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 11770508)

  • 1. Clot-buster proves safe, effective when given during first three hours after a stroke.
    Rep Med Guidel Outcomes Res; 2000 Mar; 11(6):7-8. PubMed ID: 11770508
    [No Abstract]   [Full Text] [Related]  

  • 2. Taming the clot-buster tPA.
    Dawson TM; Dawson VL
    Nat Med; 2006 Sep; 12(9):993-4. PubMed ID: 16960567
    [No Abstract]   [Full Text] [Related]  

  • 3. Can the therapeutic window for tissue plasminogen activator be extended to 6 hours after stroke onset?
    Alexandrov AV
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):342-3. PubMed ID: 16265558
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant tissue plasminogen activator for acute ischemic stroke.
    Al-Buhairi AR; Jan MM
    Saudi Med J; 2002 Jan; 23(1):13-9. PubMed ID: 11938357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience.
    Simon JE; Sandler DL; Pexman JH; Hill MD; Buchan AM;
    Age Ageing; 2004 Mar; 33(2):143-9. PubMed ID: 14960429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
    National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
    Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of tissue plasminogen activator, ischemic stroke, and potential legal issues.
    Liang BA; Lew R; Zivin JA
    Arch Neurol; 2008 Nov; 65(11):1429-33. PubMed ID: 19001160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolysis for stroke in the over 80s.
    Ford GA
    Age Ageing; 2004 Mar; 33(2):95-7. PubMed ID: 14960420
    [No Abstract]   [Full Text] [Related]  

  • 10. The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study.
    Bath PM
    Stroke; 2012 Mar; 43(3):623-4. PubMed ID: 22223236
    [No Abstract]   [Full Text] [Related]  

  • 11. Alteplase beyond three hours in ischemic stroke: do we know enough?
    Jawaid A; Fitch O; Qureshi S; Wilson AM; Schulz PE
    Int J Stroke; 2009 Apr; 4(2):70. PubMed ID: 19383044
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using tPA for acute stroke in a rural setting.
    Edwards LL
    Neurology; 2007 Jan; 68(4):292-4. PubMed ID: 17242335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue plasminogen activator-induced reperfusion injury after stroke revisited.
    Hermann DM; Matter CM
    Circulation; 2007 Jul; 116(4):363-5. PubMed ID: 17646593
    [No Abstract]   [Full Text] [Related]  

  • 16. Stroke treatment: beyond the three-hour window and in the pregnant patient.
    Cronin CA; Weisman CJ; Llinas RH
    Ann N Y Acad Sci; 2008 Oct; 1142():159-78. PubMed ID: 18990126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombolytic treatment in stroke in patients with intracardiac thrombus: presentation of one case].
    Segura T; Herrera M; Garcia-Muñozguren S; Zorita MD
    Neurologia; 2005 Apr; 20(3):149-52. PubMed ID: 15815951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteplase for acute ischemic stroke.
    Gonzales NR; Grotta JC
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):301-18. PubMed ID: 16716092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study.
    Kwiatkowski T; Libman R; Tilley BC; Lewandowski C; Grotta JC; Lyden P; Levine SR; Brott T;
    Ann Emerg Med; 2005 Apr; 45(4):377-84. PubMed ID: 15795715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined stroke trial data confirms that early treatment with thrombolytics improves outcomes.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Apr; 15(7):8-9. PubMed ID: 15101394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.